Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director

EPISODE · Apr 8, 2020 · 12 MIN

Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director

from Morgans Under the Microscope · host Morgans Financial Limited

Morgans Research Analyst Iain Wilkie talks with Mark Diamond, Managing Director of Antisense Therapeutics (ASX:ANP). Mark shares a recap on what the company does, and what potential investors can look out for.

NOW PLAYING

Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director

0:00 12:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

URL copied to clipboard!